Journal Logo

February 2004 - Volume 32 - Issue 2
pp: 327-624

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*

Opal, Steven; Laterre, Pierre-Francois; Abraham, Edward; More

Critical Care Medicine. 32(2):332-341, February 2004.

Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: Incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels*

Dimopoulou, Ioanna; Tsagarakis, Stylianos; Kouyialis, Andreas T.; More

Critical Care Medicine. 32(2):404-408, February 2004.

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces the development of nonseptic shock induced by zymosan in mice*

Cuzzocrea, Salvatore; Pisano, Barbara; Dugo, Laura; More

Critical Care Medicine. 32(2):457-466, February 2004.

Neutrophil depletion attenuates interleukin-8 production in mild-overstretch ventilated normal rabbit lung

Kotani, Mariko; Kotani, Toru; Ishizaka, Akitoshi; More

Critical Care Medicine. 32(2):514-519, February 2004.

Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit

Dempfle, Carl-Erik H.; Lorenz, Stephan; Smolinski, Mathias; More

Critical Care Medicine. 32(2):520-524, February 2004.

Systemic, pulmonary, and hepatosplanchnic effects of N-acetylcysteine during long-term porcine endotoxemia*

Vassilev, Damian; Hauser, Balázs; Bracht, Hendrik; More

Critical Care Medicine. 32(2):525-532, February 2004.